Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2013

Conditions

Asthma

Interventions

DRUG

Placebo matching Respimat

2 puffs a.m. via Respimat inhaler

DRUG

Placebo matching Respimat

2 puffs a.m. via Respimat inhaler

DRUG

BI 54903 MD

2 puffs MD b.i.d. via Respimat inhaler

DRUG

BI 54903 HD

2 puffs HD p.m. via Respimat inhaler